文献速递临床试验与 GCP流行病学与生物统计

APOE4基因型对运动干预随机对照试验中生理与认知健康的影响:系统综述与荟萃分析

The effect of the APOE4 genotype on physiological and cognitive health in randomised controlled trials with an exercise intervention: a systematic review and meta-analysis.
PubMed 文献 · Trials · 2025-01-20

该系统综述与荟萃分析检索MEDLINE、EMBASE和PsycINFO,纳入19项运动干预随机对照试验进行系统综述、3项进行荟萃分析,评估APOE4基因型是否影响运动对生理与认知结局的效果。极低至中等质量证据显示APOE4携带者在认知和部分生理结局上获益更多,非携带者在另一些生理和认知标志物上获益更多;荟萃分析中物理功能结局无差异证据(极低质量)。结论受证据质量限制,需按APOE状态分层开展进一步随机对照试验。

要点

  • 极低至中等质量证据显示APOE4携带者与非携带者在运动后的认知和生理结局上获益方向不一。
  • 荟萃分析(极低质量证据)未发现APOE4携带者与非携带者在物理功能结局上有差异证据。
  • 研究设计与报告存在需改进之处,包括相对运动强度的维持和完整的统计报告。

核心结论

  • 该系统综述发现非常有限的证据提示运动干预可使APOE4携带者与非携带者同等获益,但结论受证据质量限制。
  • 作者认为需按APOE状态分层开展进一步随机对照试验,以更好理解APOE基因型与运动对健康相关结局影响的关系。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE和PsycINFO,纳入不同认知能力的运动干预随机对照试验。
  • 19项研究符合系统综述纳入标准,3项纳入荟萃分析。
  • 开展了质量评估;本综述在PROSPERO注册(CRD42023436842),注册日期为2023年6月16日。

主要发现

  • 极低至中等质量证据显示,运动后APOE4携带者在认知(如执行功能、学习)和生理(如相对端粒长度)结局上比APOE4非携带者获益更多。
  • 极低至中等质量证据显示,运动后APOE4非携带者在生理(血清BDNF、步速)和认知(整体认知、言语记忆)标志物上比携带者获益更多。
  • 极低质量证据表明,荟萃分析中APOE4携带者与非携带者在物理功能结局上无差异证据。
  • 研究设计与报告多个方面需改进,包括相对运动强度的维持和完整的统计报告。

局限性

  • 结论受证据质量限制,证据质量为极低至中等。
  • 作者认为需按APOE状态分层开展进一步随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alzheimer's disease is caused by modifiable and non-modifiable risk factors. Randomised controlled trials have investigated whether the strongest genetic risk factor for Alzheimer's disease, APOE4, impacts the effectiveness of exercise on health. Systematic reviews are yet to evaluate the effect of exercise on physical and cognitive outcomes in APOE genotyped participants. A quality assessment of these randomised controlled trials is needed to understand the impact genotype has on the potential success of intervention. This systematic review aimed to determine if the APOE4 genotype influences the effectiveness of exercise-based randomised controlled trials. METHOD: Searches on MEDLINE, EMBASE, and PsycINFO identified eligible exercise based randomised controlled trials incorporating participants with varied cognitive abilities. Quality assessments were conducted. RESULTS: Nineteen studies met the inclusion criteria for systematic review, and 3 for the meta-analysis. Very low to moderate quality evidence showed that APOE4 carriers benefitted more than APOE4 non-carriers on cognitive (e.g. executive function, learning) and physical (e.g. relative telomere length) outcomes after exercise; and that APOE4 non-carriers benefited over carriers for physical (serum BDNF, gait speed) and cognitive (global cognition, verbal memory) markers. Very low quality evidence indicated that there was no evidence of difference between APOE4 carriers and non-carriers on physical function outcomes in meta-analysis. Several areas of study design and reporting, including maintenance of relative exercise intensity and complete statistical reporting, were identified as needing improvement. DISCUSSION: This systematic review found very limited evidence to suggest that exercise interventions can benefit APOE4 carriers and non-carriers equally, though conclusions were limited by evidence quality. Further randomised controlled trials, stratifying participants by APOE status are required to better understand the relationship between APOE genotype and the effect of exercise on health-related outcomes. TRIAL REGISTRATION: This review was registered with PROSPERO (CRD42023436842). Registered on June 16, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Spencer FSE, Elsworthy RJ, Breen L, et al. The effect of the APOE4 genotype on physiological and cognitive health in randomised controlled trials with an exercise intervention: a systematic review and meta-analysis. Trials. 2025. PMID: 39828710. doi:10.1186/s13063-024-08696-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。